BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vaidya A, Ayat N, Buford M, Wang H, Shankardass A, Zhao Y, Gilmore H, Wang Z, Lu ZR. Noninvasive assessment and therapeutic monitoring of drug-resistant colorectal cancer by MR molecular imaging of extradomain-B fibronectin. Theranostics 2020;10:11127-43. [PMID: 33042274 DOI: 10.7150/thno.47448] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Saw PE, Xu X, Kang BR, Lee J, Lee YS, Kim C, Kim H, Kang SH, Na YJ, Moon HJ, Kim JH, Park YK, Yoon W, Kim JH, Kwon TH, Choi C, Jon S, Chong K. Extra-domain B of fibronectin as an alternative target for drug delivery and a cancer diagnostic and prognostic biomarker for malignant glioma. Theranostics 2021;11:941-57. [PMID: 33391514 DOI: 10.7150/thno.44948] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Innao V, Rizzo V, Allegra AG, Musolino C, Allegra A. Promising Anti-Mitochondrial Agents for Overcoming Acquired Drug Resistance in Multiple Myeloma. Cells 2021;10:439. [PMID: 33669515 DOI: 10.3390/cells10020439] [Reference Citation Analysis]
3 Schilb AL, Ayat NR, Vaidya AM, Hertz LM, Hall RC, Scheidt JH, Sun D, Sun Z, Gopalakrishnan R, Lu ZR. Efficacy of Targeted ECO/miR-200c Nanoparticles for Modulating Tumor Microenvironment and Treating Triple Negative Breast Cancer as Non-invasively Monitored by MR Molecular Imaging. Pharm Res 2021;38:1405-18. [PMID: 34389916 DOI: 10.1007/s11095-021-03083-z] [Reference Citation Analysis]
4 Lv S, Song B, Han F, Li Z, Fan B, Zhang R, Zhang J, Li J. MXene-based hybrid system exhibits excellent synergistic antibiosis. Nanotechnology 2021;33. [PMID: 34757944 DOI: 10.1088/1361-6528/ac385d] [Reference Citation Analysis]